Keywords: therakos/icn, trial, protocol, approved, uvar, photopheresis, device

THERAKOS/ICN TRIAL PROTOCOL APPROVED

Article | 29 March 1993

Print This

- A trial of Therakos/ICN's Uvar photopheresis device in combination with Oxsoralen (methoxsalen) for the treatment of scleroderma has been ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in